A healthcare professional will prepare a dose of the Oxford / AstraZeneca Covid-19 vaccine at the vaccine center at the Brighton Center in Brighton, southern England on January 26, 2021.
Ben Stensall | AFP | Getty Images
LONDON – The results of a large US study showed that the coronavirus vaccine developed by AstraZeneca and the University of Oxford is 79% effective in preventing symptomatic illness and 100% effective against serious illness and hospitalization.
The results were published on Monday.
It comes shortly after a spate of countries temporarily suspended the use of the shot after reports of blood clots in some vaccinated people.
Germany, France, Italy and Spain are among those who have resumed use of the Oxford-AstraZeneca vaccine after the European Medicines Agency found the shot was safe and effective during its initial investigation into possible side effects.
This is a developing story and will be updated shortly.
After returning to Los Angeles, the Her Friends and Neighbors star shared children Frances19, Molly15,…
Cuba suffered a widespread power outage on March 16, 2026, according to the national electric…
Lights shine on skyscrapers and commercial buildings across the skyline of the City of London,…
The Rivian R2 is on display during the 2025 Los Angeles Auto Show at the…
Shares of Eli Lilly fell 6% on Tuesday and are on track for their worst…
The White House described Trump's press conference with Vice President JD Vance as evidence that…
This website uses cookies.